drugset / Trial / NCT01615003

The Study of MicroRNA Genomics of Blood Stasis Syndrome and of Coronary Heart Disease

NCT01615003 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

In this study, typical cases of blood stasis syndrome of coronary heart disease are selected, by using microRNA chip, cDNA microarray and other bioinformatics technologies to filter and verify related miRNA and its target gene of Coronary Heart disease. Meanwhile, intervene by Xuesaitong soft capsules to investigate related miRNA and its target gene of Coronary Heart disease.

Timeline

Start
2012-05
Primary completion
2014-07
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Xuesaitong Unknown — Oral